Categories
Links

Linkfest:Aug 14, 2013

Some stuff I am reading today morning:

Brokers:Will go to court if NSEL dues are not paid (Moneycontrol)

Jim Rogers:Why I am shorting India (Mint)

FMCG companies feel the pinch (BS)

Carl Icahn takes a bite of Apple (Bloomberg)

Bangalore Property’s revised guidance value (BasuNivesh)

I-Day:Mercury rising, so is Modi (Mediacrooks)

Why should you take your health in your own hands (DailyReckoning)

Do dividends make 90% of stock market returns? (CrossingWallStreet)

The most expensive homes for sale in the US (BI)

Does this nation really have a Prime Minister? (SandeepWeb)

Categories
Tweets

State of economy explained in 12 words

Categories
Video

Asia’s wealthy invest in jade

Categories
Links

Linkfest:August 13, 2013

Some stuff that I am reading today morning:

Has Narendra Modi just scuttled the Food Bill? (Firstpost)

908 stocks on BSE trade below their face value (BS)

Foreign brokers turn bearish on Indian markets (ET)

Why is it important to prove Robert Vadra is guilty (Firstpost)

India’s F1 builder with $10 Billion debt to sell assets (Bloomberg)

Diversification isn’t broken (NYTimes)

Why you need an investment philosophy (Morningstar)

The best hedge fund you have never heard of (Turnkey)

Is day trading really a sucker’s game? (BCLund)

Dry powder is an asset not a failing (Aimlessly)

Categories
Observations

The gut wrenching fall of Wockhardt Ltd

Wockhardt Ltd is one of India’s leading pharma companies with annual sales of $1 Billion. Its corporate headquarters is housed in a gleaming building right next to National Stock Exchange in Mumbai.

On April 1, 2013, Wockhardt was trading at around Rs.2025 per share.Around a month later,MSCI added to its index which is a good sign for any scrip.

On 24th May, 2013,Wockhardt released the following press release to the stock exchanges:

Wockhardt Limited has informed the Exchange that the Company has received an ‘import alert’ from USFDA on one of its manufacturing unit located in Waluj near Aurangabad. The impact of the import alert on the revenues is estimated to be in the range of $100m on an annualised basis. The Company is taking all steps to address the concerns raised by USFDA and shall put all efforts to resolve the issue at the earliest.

 

All hell broke lose following this announcement.The stock kept falling and is now quoting at around 400 Rs/share !

This is around 25% of its quoted value only 4 months back !

The moral of the story:Invest in the Indian Equity Markets only if you can stomach the volatility !